MutSpliceDB: A database of splice sites variants with RNA-seq based evidence on effects on splicing.


Journal

Human mutation
ISSN: 1098-1004
Titre abrégé: Hum Mutat
Pays: United States
ID NLM: 9215429

Informations de publication

Date de publication:
04 2021
Historique:
revised: 02 11 2020
received: 28 08 2020
accepted: 13 02 2021
pubmed: 19 2 2021
medline: 1 4 2022
entrez: 18 2 2021
Statut: ppublish

Résumé

Splice site variants may lead to transcript alterations, causing exons inclusion, exclusion, truncation, or intron retention. Interpreting the consequences of a specific splice site variant is not straightforward, especially if the variant is located outside of the canonical splice sites. We developed MutSpliceDB: https://brb.nci.nih.gov/splicing, a public resource to facilitate the interpretation of splice sites variants effects on splicing based on manually reviewed RNA-seq BAM files from samples with splice site variants.

Identifiants

pubmed: 33600011
doi: 10.1002/humu.24185
pmc: PMC9867871
mid: NIHMS1863252
doi:

Substances chimiques

RNA Splice Sites 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

342-345

Subventions

Organisme : Intramural NIH HHS
ID : Z99 CA999999
Pays : United States

Informations de copyright

Published 2021. This article is a U.S. Government work and is in the public domain in the USA.

Références

Nature. 2019 May;569(7757):503-508
pubmed: 31068700
Nucleic Acids Res. 2019 Jan 8;47(D1):D941-D947
pubmed: 30371878
Nature. 2012 Mar 28;483(7391):603-7
pubmed: 22460905
Nucleic Acids Res. 2016 Jan 4;44(D1):D862-8
pubmed: 26582918
Nature. 2016 Aug 17;536(7616):285-91
pubmed: 27535533
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
Hum Mutat. 2017 Nov;38(11):1449-1453
pubmed: 28762582
Nature. 2015 Aug 6;524(7563):47-53
pubmed: 26168399
J Thorac Oncol. 2009 Jan;4(1):5-11
pubmed: 19096300
Hum Mutat. 2018 Nov;39(11):1690-1701
pubmed: 30311374
Hum Mutat. 2016 Sep;37(9):865-76
pubmed: 27328919
Nat Biotechnol. 2011 Jan;29(1):24-6
pubmed: 21221095
Nat Genet. 2013 Oct;45(10):1113-20
pubmed: 24071849

Auteurs

Alida Palmisano (A)

Division of Cancer Treatment and Diagnosis, Biometric Research Program, National Cancer Institute, Rockville, Maryland, USA.
General Dynamics Information Technology, Falls Church, Virginia, USA.

Suleyman Vural (S)

Division of Cancer Treatment and Diagnosis, Biometric Research Program, National Cancer Institute, Rockville, Maryland, USA.

Yingdong Zhao (Y)

Division of Cancer Treatment and Diagnosis, Biometric Research Program, National Cancer Institute, Rockville, Maryland, USA.

Dmitriy Sonkin (D)

Division of Cancer Treatment and Diagnosis, Biometric Research Program, National Cancer Institute, Rockville, Maryland, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH